CopyMark Law Group
4.9
Drawing for OYSTA

USPTO serial 79361344

OYSTA

Reviewed by CopyMark Law Group

Reg. 7410759Status 700Registered
Filing date
Status date
Registration date
Jun 11, 2024
Examiner
BARRETT, LEAH N
Law office
TMEG LAW OFFICE 106

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with OYSTA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Goods and services

ClassDescriptionStatusFirst use
005Multiple-dose container filled with pharmaceuticals, in particular with pellets and tablets, for the treatment of neurodevelopmental diseases; Multiple-dose container filled with pharmaceuticals, in particular with pellets and tablets, for the treatment of neurological diseases; Multiple-dose container filled with pharmaceuticals, in particular with pellets and tablets, for the treatment of immune system diseases and disorders, including immunosuppressants; Multiple-dose container filled with pharmaceuticals, in particular with pellets and tablets, for the treatment of pulmonary hypertension; Multiple-dose container filled with pharmaceuticals, in particular with pellets and tablets, for the treatment of painACTIVE—
009Downloadable computer and mobile application software for use in dosing pharmaceuticals and medication managementACTIVE—
010Medical dispensers with dosage function for administering pharmaceuticals, in particular for pharmaceuticals in the form of pellets and tabletsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 17, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 17, 2025ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Jun 17, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 17, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 14, 2024FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 21, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 21, 2024FIMPFINAL DISPOSITION PROCESSED—
Sep 11, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 11, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jun 11, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 26, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 26, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 6, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 6, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 16, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 16, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Feb 16, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 16, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 16, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 12, 2024LIMELIMITATION FROM THE IB - REQUEST EXAM REVIEW—
Jan 10, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 9, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 9, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 2, 2023LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Sep 4, 2023RFNTREFUSAL PROCESSED BY IB—
Aug 17, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 17, 2023RFRRREFUSAL PROCESSED BY MPU—
Jul 19, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 18, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 12, 2023DOCKASSIGNED TO EXAMINER—
Feb 7, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 3, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 2, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance